Apple AirPods Pro 3 vs RxEars Rxi

The Apple AirPods Pro 3 is a budget-priced OTC hearing aid released in 2025, earning a B grade with a SoundScore of 3.3/5 in our lab testing. At $250, it sits in the most affordable price tier of OTC devices, though its overall sound performance ranks #49 of 65 in the category. This device delivers standout performance in music streaming, scoring a strong 4.3/5—a full 2.38 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect excellent stability without whistling or squealing during normal use. These strengths make the AirPods Pro 3 particularly appealing for users who prioritize media consumption alongside hearing assistance. However, speech clarity presents a more mixed picture. Speech in quiet scores 2.3/5, falling 0.53 points below the category average. Speech in noise measures 1.8/5, which is above the category average but still low in absolute terms. Own-voice comfort also trails at 1.9/5, sitting 0.61 points below typical OTC performance. The AirPods Pro 3 is best suited for users already invested in the Apple ecosystem who want hearing assistance combined with premium streaming quality. Those prioritizing speech understanding in conversations may want to explore alternatives like the Apple AirPods Pro 2, which scores higher overall at a lower listed price, or the Elehear Beyond at the top of this price range.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it represents one of the most affordable options in the prescription hearing aid category while still delivering solid overall performance. Speech clarity is a notable strength for this device. In quiet listening environments, the Rxi scores 4.3/5, which is 0.97 points above the category average—a strong result that should benefit users in conversational settings at home or in calm environments. Speech understanding in noisy conditions scores 2.1/5, slightly above the category average by 0.16 points, though this remains mixed in absolute terms and may present challenges in demanding acoustic situations like busy restaurants. Feedback handling is excellent at 4.7/5, essentially matching the category average and indicating reliable stability during daily wear. However, the Rxi shows notable limitations in other areas. Own-voice comfort scores 1.6/5, falling 1.15 points below the category average, which may result in a hollow or boomy perception of your own voice. Music streaming is not supported, scoring 0.0/5—a significant gap of 2.64 points below category average that buyers should consider if streaming audio matters to them. The RxEars Rxi is best suited for budget-conscious consumers who prioritize speech clarity in quieter environments and don't require streaming capabilities. Its invisible form factor and disposable battery design offer convenience, though those seeking better own-voice comfort or music features should explore alternatives.